3D QSAR studies on cinnamaldehyde analogues as farnesyl protein transferase inhibitors

Archives of Pharmacal Research

Volumn 27, Issue 10, 2004, Pages 1001-1008

  Sung, Nack Do ^a   Cho, Young Kwon ^a   Kwon, Byoung Mog ^b   Kwan, Hoon Hyun ^c   Chan, Kyung Kim ^c  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Inha University   (South Korea)

Author keywords

3D QSAR; Cinnamaldehyde inhibitors; CoMFA; Farnesyl protein transferase

Indexed keywords

ACROLEIN; CINNAMALDEHYDE; DRUG DERIVATIVE; ENZYME INHIBITOR; P21(RAS) FARNESYL PROTEIN TRANSFERASE; P21(RAS) FARNESYL-PROTEIN TRANSFERASE; TRANSFERASE;

ALGORITHM; ARTICLE; ARTIFICIAL INTELLIGENCE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; ELECTROCHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCIBILITY; SYNTHESIS;

ACROLEIN; ALGORITHMS; ALKYL AND ARYL TRANSFERASES; ARTIFICIAL INTELLIGENCE; ELECTROCHEMISTRY; ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS;

EID: 16644365167     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02975421     Document Type: Article

References (22)

1. Adari, H., Lowy, D. R., Willumsen, B. M., Der, C. J., and McCormick, F., Guanosine triphosphate activating protein (GAP) interacts with the p21 ras effector binding domain. Science, 240, 518-521 (1988).
2. Cho, S. J., Garsia, M. L. S., Bier, J., and Tropsha, A., Structurebased alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. J. Med. Chem., 39, 5064-5071 (1996).
3. Cho, Y. K., CoMFA on Cinnamaldehyde Analogues against FPTase Inhibitory Acitivity, Ph.D. thesis, Graduate school of Chungnam National University, Korea (2002).
4. Choo, H.-Y. P., Choi, S., Ryu, C.-K., Kim, H.-J., Lee, I. Y., Pae, A. N., and Koh, H. Y., QSAR study of quinolinediones with inhibitory activity of endothelium-dependent vasorelaxation by CoMSIA. Bioorg. Med. Chem., 11, 2019-2023 (2003).
5. Forina, M., Casolino, C., and Millan, C. P., Iterative predictor weighting (IPW) PLS: a technique for the elimination of useless predictors in regression problems. J. Chemometr, 13, 165-184 (1999).
6. Gibbs, J. B. and Oliff A., Pharmaceutical research in molecular oncology. Cell, 79, 193-198 (1994).
7. Huang, M., Yang, D.-Y., Shang, Z., Zou, J., and Yu, Q., 3D-QSAR studies on 4-hydroxyphenylpyruvate dioxygenase inhibitors by comparative molecular field analysis (CoMFA). Bioorg. Med. Chem. Lett., 12, 2271-2275 (2002).
8. Knight, D. W., Feverfew: chemistry and biological activity. Nat. Prod. Rep., 12, 271-276 (1995).
9. Kwon, B. M., Cho, Y. K., and Lee, S. H., 2′-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia. Planta Medica, 62, 183-184 (1996).
10. Kwon, B. M., Lee, S. H., Cho, Y. K., Bok, S. H., So, S. H., Youn, M. R., and Chang, S. I., Synthesis and biological activity of cinnamaldehyde as angiogenesis inhibitors. Bioorg. Med. Chem. Lett., 7, 2473-2476 (1997).
11. Kwon, B. M., Lee, S. H., Choi, S. U., Park, S. H., Lee, C. O., Cho, Y. K., Sung, N. D., and Bok, S. H., Synthesis and in vitro cytotoxicity of cinnamaldehyde to human solid tumor cells. Arch. Pharm. Res., 21, 147-152 (1998).
12. Lindgren F, Geladi P, Rännar S, and Wold S., Interactive Variable Selection (Ivs) For Pls .1. Theory and Algorithms. J. Chemometr., 8, 349-363 (1994).
13. Lodish, H., Berk, A., Zipursky, S. L., Matsudaira, P., Baltimore, D., and Darnell, J., Molecular Cell Biology, W. H. Freeman and Company, New York, (1995).
14. Pedretti, A., Villa, L., and Vistoli, G., Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. J. Med. Chem., 45, 1460-1465 (2002).
15. Podlogar, B. L., Muegge, I., and Brice, L. J., Computational methods to estimate drug development parameters. Curr. Opin. Drug Discovery Dev., 4, 102-109 (2001).
16. Qian, Y., Blaskovich, M. A., Saleem, M., Seong, C. M., Wathen, S. P., Hamilton, A. D., and Sebti, S. M., Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase, J. Biol. Chem., 269, 12410-12413 (1994).
17. Raichurkar, A. V. and Kulkarni, V. M., Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA. J. Med. Chem., 46, 4419-4427 (2003).
18. ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell, 62, 81-88 (1990).
19. Schweins, T., Geyer, M., Scheffzek, K., Warshel, A., Kalbitzer, H. R., and Wittinghofer, A., Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21ras and other GTPbinding proteins. Nat. Struct. Biol., 2, 36-44 (1995).
20. Sung, N.-D., Cheun, Y. G., Kwon, B.-M., Park, H.-Y., and Kim, C. K., Modeling of inhibition mechanism of natural ligands to farnesyl protein transferase using molecular docking. Bull. Kor. Chem. Soc., 24, 1509-1511 (2003).
21. Wu, T.-S., Ou, L.-F., and Teng, C.-M., Aristolochic acids, aristolactam alkaloids and amides from Aristolochia kankauensis. Phytochemistry, 36, 1063-1068 (1994).
22. Zhu, L., Hou, T., and Xu, X., Three-dimensional quantitative structure-activity relationship study on paullones as CDK inhibitors using CoMSIA and CoMFA. J. Mol. Model., 7, 223-230 (2001).